Acquisition by Michael Farrell of 13507 shares of ResMed at 84.98 subject to Rule 16b-3

RMD Stock  USD 244.92  4.10  1.65%   
About 54% of ResMed's investor base is interested to short. The analysis of overall sentiment of trading ResMed Inc stock suggests that many investors are impartial at this time. The current market sentiment, together with ResMed's historical and current headlines, can help investors time the market. In addition, many technical investors use ResMed Inc stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by ResMed Inc Officer Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 13507 resmed common stock at 84.98 of ResMed by Michael Farrell on 16th of June 2024. This event was filed by ResMed Inc with SEC on 2024-05-07. Statement of changes in beneficial ownership - SEC Form 4. Michael Farrell currently serves as chief executive officer, director of ResMed Inc

Cash Flow Correlation

ResMed's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the ResMed's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

ResMed Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards ResMed can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ResMed Inc Historical Investor Sentiment

Investor biases related to ResMed's public news can be used to forecast risks associated with an investment in ResMed. The trend in average sentiment can be used to explain how an investor holding ResMed can time the market purely based on public headlines and social activities around ResMed Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ResMed's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ResMed and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ResMed news discussions. The higher the estimate score, the more favorable the investor's outlook on ResMed.

ResMed Fundamental Analysis

We analyze ResMed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

ResMed is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

ResMed Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ResMed stock to make a market-neutral strategy. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics with similar companies.

Peers

ResMed Related Equities

MMSIMerit Medical   0.90   
0%
18.0%
TFXTeleflex Incorporated   0.76   
0%
16.0%
BDXBecton Dickinson   0.41   
0%
8.0%
BAXBaxter International   0.47   
9.0%
0%
HOLXHologic   0.63   
13.0%
0%
ALCAlcon AG   0.70   
14.0%
0%
WSTWest Pharmaceutical   0.93   
19.0%
0%
EMBCEmbecta Corp   1.01   
21.0%
0%
COOCooper Companies,   1.40   
29.0%
0%
ICUIICU Medical   1.83   
38.0%
0%
STAASTAAR Surgical   4.74   
100.0%
0%

Complementary Tools for ResMed Stock analysis

When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Valuation
Check real value of public entities based on technical and fundamental data